Mengdi He
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 5
- Immune cells in cancer 5
- Galectins and Cancer Biology 1
- Reproductive System and Pregnancy 1
- Oncology 8
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Haiou Liu (11 shared papers)Moran Yang (11 shared papers)Guodong Zhang (10 shared papers)Jiaqi Lu (8 shared papers)Yiying Wang (7 shared papers)Qing Xu (3 shared papers)Congjian Xu (3 shared papers)Xiangyun Zhang (1 shared paper)
- Journals
- OncoImmunology (2 papers)Cancer Medicine (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Cancer Research (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- China
In The Last Decade
Mengdi He
12 papers receiving 332 citations
Peers
Comparison fields: 5 of 55
- Immunology 222
- Oncology 181
- Reproductive Medicine 33
- Cancer Research 56
- Pulmonary and Respiratory Medicine 53
Countries citing papers authored by Mengdi He
This map shows the geographic impact of Mengdi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdi He more than expected).
Fields of papers citing papers by Mengdi He
This network shows the impact of papers produced by Mengdi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdi He. The network helps show where Mengdi He may publish in the future.
Co-authors
The 17 scholars most cited alongside Mengdi He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 154 | |
| 2 | 2020 | 55 | |
| 3 | 2021 | 28 | |
| 4 | 2021 | 25 | |
| 5 | 2023 | 23 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 12 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 8 | |
| 10 | 2025 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2025 | 1 |
About Mengdi He
Mengdi He is a scholar working on Immunology, Oncology, Molecular Biology, Rheumatology and Obstetrics and Gynecology, having authored 12 papers that have together received 338 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers), Immune cells in cancer (5 papers), Single-cell and spatial transcriptomics (1 paper), Galectins and Cancer Biology (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper) and Reproductive System and Pregnancy (1 paper). The work is most often cited by research in Immunology (222 citations), Oncology (181 citations), Reproductive Medicine (33 citations), Cancer Research (56 citations) and Pulmonary and Respiratory Medicine (53 citations). Mengdi He has collaborated with scholars based in China. Frequent co-authors include Haiou Liu, Moran Yang, Guodong Zhang, Jiaqi Lu, Yiying Wang, Qing Xu, Congjian Xu, Xiangyun Zhang, Hongwei Zhang and Yan Huang. Their work appears in journals such as OncoImmunology, Cancer Medicine, Journal for ImmunoTherapy of Cancer, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.